Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 148,37
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 309 pages. 9.25x7.50x0.71 inches. In Stock.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 158,63
Anzahl: 3 verfügbar
In den WarenkorbZustand: New.
Zustand: New.
Sprache: Englisch
Verlag: Elsevier Science Publishing Co Inc, 2021
ISBN 10: 0128225270 ISBN 13: 9780128225271
Anbieter: THE SAINT BOOKSTORE, Southport, Vereinigtes Königreich
EUR 171,97
Anzahl: Mehr als 20 verfügbar
In den WarenkorbHardback. Zustand: New. New copy - Usually dispatched within 4 working days.
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Zustand: New.
Hardcover. Zustand: New. New Hardcover printed hardcover - No dj issued: --Shrink Wrapped:
Anbieter: Brook Bookstore On Demand, Napoli, NA, Italien
EUR 138,55
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: new. Questo è un articolo print on demand.
Sprache: Englisch
Verlag: Elsevier Science Mär 2021, 2021
ISBN 10: 0128225270 ISBN 13: 9780128225271
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -New Targeting in The Reversal of Resistant Glioblastomas discusses alternative treatment strategies that not only target tumor cells but also target the tumor microenvironment, metabolic pathways and interaction of cytokines in tumor cells. The current treatment for primary and recurrent glioblastomas is failing because clinicians are not considering the effect of bone marrow derived cells to the development of resistance to clinically practiced therapies. This book helps readers rethink treatment strategies to successfully fight glioblastomas. It is a valuable resource for cancer researchers, clinicians, graduate students and other members of the biomedical field. 202 pp. Englisch.
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - New Targeting in The Reversal of Resistant Glioblastomas discusses alternative treatment strategies that not only target tumor cells but also target the tumor microenvironment, metabolic pathways and interaction of cytokines in tumor cells. The current treatment for primary and recurrent glioblastomas is failing because clinicians are not considering the effect of bone marrow derived cells to the development of resistance to clinically practiced therapies. This book helps readers rethink treatment strategies to successfully fight glioblastomas. It is a valuable resource for cancer researchers, clinicians, graduate students and other members of the biomedical field.